Park Ha Biological Technology Co., Ltd. Ordinary Shares
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BYAH · as of 2026-06-08
Financial statements
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.52M | $2.38M | $2.46M | $1.92M | $0.93M |
| Cost of Revenue | $0.14M | $0.20M | $0.31M | $0.51M | $0.31M |
| Gross Profit | $2.38M | $2.19M | $2.15M | $1.41M | $0.62M |
| Gross Margin %(computed) | 94.36% | 91.80% | 87.35% | 73.47% | 66.58% |
| Operating Expenses | |||||
| R&D Expenses | $0.24M | $0.04M | $0.03M | $0.06M | $0.00M |
| G&A Expenses | $25.48M | $0.81M | $0.48M | $0.71M | $0.75M |
| Total Operating Expenses | $26.53M | $1.39M | $0.97M | $1.21M | $1.12M |
| Operating Income | ($24.15M) | $0.79M | $1.18M | $0.20M | ($0.50M) |
| Operating Margin %(computed) | -956.45% | 33.32% | 48.01% | 10.26% | -53.81% |
| Interest Income | $0.01M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($24.08M) | $0.79M | $1.18M | $0.19M | ($0.48M) |
| Income Tax Expense | $0.28M | $0.31M | $0.33M | ($0.00M) | $0.00M |
| Net Income | ($24.36M) | $0.48M | $0.85M | $0.19M | ($0.48M) |
| Net Margin %(computed) | -965.00% | 20.09% | 34.65% | 9.97% | -52.09% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-41.38 | $0.92 | $1.63 | $0.36 | $-0.93 |
| Wtd Avg Shares | 0.59M | 0.52M | 0.52M | 0.52M | 0.52M |
| EBITDA | ($23.97M) | $0.82M | $1.20M | $0.22M | ($0.44M) |
| EBITDA Margin %(computed) | -949.55% | 34.26% | 48.86% | 11.50% | -47.77% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Park Ha Biological Technology Co., Ltd. Ordinary Shares data
About Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Income Statement
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BYAH reported revenue of $0.00B, gross profit of $0.00B (gross margin 94.36%), and net income of ($0.02B) — a net profit margin of -965.00%.
Frequently asked questions
BYAH · 4 questionsPark Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reported revenue of $0.00B for 2025, up 6.0% year-over-year.
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08